Ashwin Mehta analyst AMBIT

Currently out of the existing stock ratings of Ashwin Mehta, 4 are a BUY (30.77%), 4 are a HOLD (30.77%), 5 are a SELL (38.46%).

Ashwin Mehta

Work Performance Price Targets & Ratings Chart

Analyst Ashwin Mehta, currently employed at AMBIT, carries an average stock price target met ratio of 100% that have a potential upside of 15.81% achieved within 457 days. Previously, Ashwin Mehta worked at NOMURA.

Ashwin Mehta’s has documented 25 price targets and ratings displayed on 3 stocks. The coverage is on Technology, Consumer Cyclical sectors.

Most recent stock forecast was given on INFY, Infosys Ltd ADR at 14-Apr-2023.

Wall Street Analyst Ashwin Mehta

Analyst best performing recommendations are on MMYT (MAKEMYTRIP).
The best stock recommendation documented was for MMYT (MAKEMYTRIP) at 11/27/2018. The price target of $31 was fulfilled within 99 days with a profit of $7.35 (31.08%) receiving and performance score of 3.14.

Average potential price target upside

CTSH Cognizant Technology Solutions Corp MMYT MakeMyTrip INFY Infosys Ltd ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 01-Oct-2026

$70

$10.8 (18.24%)

$70

6 days ago
(08-Oct-2026)

2/5 (40%)

$10.8 (18.24%)

83

Hold Since 02-Aug-2023

$54

$-5.2 (-8.78%)

$54

27 days ago
(17-Sep-2026)

27/34 (79.41%)

$-5.87 (-9.80%)

433

Hold Since 07-May-2020

$60

$0.8 (1.35%)

$45

2 months 15 days ago
(29-Jul-2026)

25/28 (89.29%)

$6.41 (11.96%)

189

Buy Since 21-Oct-2025

$67

$7.8 (13.18%)

$61

2 months 15 days ago
(29-Jul-2026)

20/26 (76.92%)

$13.41 (25.02%)

441

Buy Since 22-Jan-2026

$82

$22.8 (38.51%)

$88

2 months 15 days ago
(29-Jul-2026)

6/16 (37.5%)

$28.41 (53.01%)

819

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Ashwin Mehta?

On 2013
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?